Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cardiostatil PLUS is a multi-ingredient dietary supplement developed and marketed by Aflofarm Farmacja Polska. It is designed to support the maintenance of normal blood cholesterol levels and overall cardiovascular health in adults. The primary active component is monacolin K (2.75 mg), a compound derived from fermented red rice that is chemically identical to the statin drug lovastatin and functions as an HMG-CoA reductase inhibitor. The formulation also includes 250 mg of bergamot fruit extract (standardized to 150 mg of polyphenols), garlic extract, artichoke leaf extract, vitamin B6, vitamin B12, folic acid, and chromium. It is available over-the-counter in capsule form and is typically administered as one capsule daily with a meal.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cardiostatil PLUS.